In today’s Pharma Pulse, the FDA launches its "PreCheck" pilot to speed up domestic factory approvals, while new SELECT trial data shows that semaglutide significantly slashes hospital admission rates ...
2023 should have been a recovery year for the supply chain, following the major disruptions of 2022, but problems remained with parts shortages and shipping problems. Will 2024 be any better? A group ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results